OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2025
(3)
2020
(2)
2024
(1)
2023
(1)
2021
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Clinical value of D-dimer combined with transvaginal ultrasonography in the postmenopausal population with endometrial carcinoma.
Not available
S-EPMC12304256
|
biostudies-literature
Cite
Clinical characteristics and plasma antibody titer of patients with COVID-19 in Zhejiang, China.
Not available
S-EPMC7759456
|
biostudies-literature
Cite
Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study.
Not available
S-EPMC8805816
|
biostudies-literature
Cite
TIM-3 blockade reverses oncolytic vaccinia virus-induced DCs inactivation and T cells exhaustion to improve antitumor immunity and therapeutic efficacy.
Not available
S-EPMC12751143
|
biostudies-literature
Cite
Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Not available
S-EPMC7216583
|
biostudies-literature
Cite
Comparing Outcomes of Thrombectomy Versus Intravenous Thrombolysis Based on Middle Cerebral Artery M2 Occlusion Features.
Not available
S-EPMC11122739
|
biostudies-literature
Cite
Deriving consensus sepsis clusters via goal-directed subgroup identification in multi-omics study.
Not available
S-EPMC12644673
|
biostudies-literature
Cite
Rationale and design of a comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided intervention strategy for clinical outcomes in patients with coronary artery disease: a randomised controlled trial (FLAVOUR II).
Not available
S-EPMC10729220
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets